Rotella Capital Management’s NeoGenomics NEO Stock Holding History

Rotella Capital Management’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-11,879	Closed	-$64K	–	632
2015 Q2	$64K	Buy	+11,879	New	+$61.3K	0.05%	351
2014 Q3	–	Sell	-14,913	Closed	-$50K	–	372
2014 Q2	$50K	Buy	+14,913	New	+$49.6K	0.04%	305

Other funds holding NEO

CRC

Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Rotella Capital Management's NEO Position: Q3 2015 in Review

Rotella Capital Management sold out of NeoGenomics (NEO) in Q3 2015, closing a stake of 11,879 shares — an estimated $64K sold.

Rotella Capital Management first reported a position in NEO in Q2 2014 and held it in 2 quarters. The position peaked at $64K in Q2 2015. 100 funds tracked by Wall St. Rank hold NEO as of Q3 2015.

Rotella Capital Management reported no remaining NeoGenomics position as of Q3 2015 after selling out during the quarter.
Rotella Capital Management sold 11,879 NeoGenomics shares in Q3 2015, an estimated $64K.
Rotella Capital Management first reported a position in NeoGenomics in Q2 2014 and held it in 2 quarters.
Rotella Capital Management's NeoGenomics position peaked at $64K in Q2 2015.
100 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2015.

Based on Rotella Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.